This patient had thyrotoxic periodic paralysisÐa condition characterized by transient localized or generalized muscle weakness or¯accid paralysis which may be of sudden onset and recurrent. It is most serious when respiratory muscles are involved. This complication of thyrotoxicosis is most common in oriental men, but can occur in men of other racial backgrounds and also in women (sex ratio 20:1) 1 . In Japan the incidence is decreasing: in 1957 it was seen in 8.6% of thyrotoxic men and 0.4% of thyrotoxic women, in 1991 4.3% and 0.4%, respectively 2 . The clinical and biochemical features of thyrotoxicosis may be subtle at the time of presentation 3 . The special susceptibility of people of Asian descent is so far unexplained. Episodes of paralysis are most common in hot humid weather. Precipitating factors include high carbohydrate foods, alcohol ingestion, strenuous exercise followed by rest, emotional stress, and treatment with insulin or acetazolamide 4,5 .
The weakness is usually symmetrical and more obvious in the lower than the upper limbs. Attacks last from a few hours to several days. The condition is customarily associated with hypokalaemia but plasma potassium may be normal 6 . In our patient, the episode of diarrhoea may have precipitated the initial episode by a hypokalaemic effect. Plasma potassium is normal between attacks. Periodic paralysis may occur with thyrotoxicosis of any cause 4 . Thyroid hormone excess is thought to increase the activity of Na + /K + -ATPase, either directly or by way of enhanced b-adrenergic activity, resulting in an intracellular shift of potassium 7 . The principal differential diagnosis is familial periodic paralysis, and the mainstay of treatment is rapid correction of thyrotoxicosis. Beta-adrenoceptor blocking drugs reduce the frequency and severity of attacks whilst potassium supplements can shorten their duration 4 . Once a euthyroid state is established, complete recovery of muscular function can be expected. The prevalence of polymyalgia rheumatica (PMR) in persons aged over 50 is about 700 per 100 000 1,2 . The diagnosis is based on a symptom complex of proximal myalgia and stiffness developing late in life usually associated with a raised erythrocyte sedimentation rate (ESR). A rapid response to low-dose oral steroids (10± 20 mg prednisolone daily) is commonly thought to support the diagnosis 3,4 . PMR is, however, a diagnosis of exclusion.
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CASE HISTORIES
Case 1
For four months a woman aged 54 had experienced proximal myalgia and stiffness, worse in the morning. ESR was 92 mm/h and alkaline phosphatase (ALP) 436 IU/L (normal5115). Other liver function tests and tests of renal and thyroid function were normal. PMR was diagnosed and she was treated with prednisolone 15 mg daily. Symptoms resolved within 3 days. One year later, on 7.5 mg prednisolone daily, she still complained of mild myalgia. ESR was 50 mm/h and ALP was 161 IU/L. Abdominal ultrasonography, arranged because of the persistently raised ALP, revealed a large mass in the left upper quadrant. A computed tomographic scan con®rmed an 11613 cm mass (Figure 1 ), which was removed at laparotomy and identi®ed as a malignant adrenal cortical tumour. Postoperatively her symptoms resolved and steroids were withdrawn without recurrence of myalgia. The ESR and ALP became normal.
Case 2
A woman aged 54 reported proximal muscle pain and stiffness, worse in the morning. No abnormalities were found on examination, and biochemical ®ndings including creatine kinase and tests of renal, hepatic and thyroid function were likewise normal. There was evidence of a mild acute-phase responseÐESR 15 mm/h, C-reactive protein 22 mg/L. PMR was diagnosed by her general practitioner, who prescribed prednisolone 15 mg daily. Symptoms improved greatly within 24 hours but recurred whenever the prednisolone was decreased below 15 mg daily. Further investigation showed a corrected calcium level of 2.7 mmol/L (normal52.6) and parathyroid hormone of 9.7 pmol/L (normal 0.9±5.4 pmol/L), results consistent with primary hyperparathyroidism. At parathyroidectomy she was found to have a parathyroid adenoma. Postoperatively her symptoms resolved within six months.
Case 3
A woman of 57 reported four months of shoulder and hip girdle pain and stiffness. No abnormalities were detected on physical examination. ESR was 70 mm/h and ALP was 161 IU/L; full blood count, calcium and muscle enzymes were normal. PMR was diagnosed, prednisolone 15 mg daily was prescribed and symptoms improved greatly within 48 hours.
Three months later, while taking 10 mg prednisolone daily, she developed severe left-sided headaches, jaw pain and scalp tenderness, associated with a rise in the ESR to 80 mm/h. Temporal arteritis was now diagnosed and the prednisolone dose was increased to 60 mg daily. Biopsy of the left temporal artery showed focal intimal ®brous proliferation but no active in¯ammation. Symptoms settled completely within two days and the ESR decreased to 42 mm/h within one month.
Three months later she was symptom-free on 30 mg prednisolone daily but her ESR and ALP remained raised at 60 mm/h and 191 IU/L respectively. An isotope bone scan showed widespread bony metastases, especially prominent in the skull, spine, femoral necks and sternum. Notably, there were several skull metastases in the left temporoparietal region, corresponding to the site of the previous pain and tenderness (Figure 2) . A bone marrow aspirate revealed metastatic adenocarcinoma of unknown origin.
COMMENT
Many conditions can mimic PMR 5,6 , and features that should raise suspicion of an alternative diagnosis include young presenting age (565 years) 2 , normal in¯ammatory markers (though these are normal in 5±20% of patients with PMR 7,8 ) and non-response to low-dose oral steroids. Another alerting feature is a persistently raised ALP. ALP is an acute-phase reactant 9 , and in one study of 74 patients with PMR it was raised in about one-third of cases 10 . However, on treatment with steroids the ALP became normal in every case within three weeks 10 . In both our patients with underlying malignancy the ALP remained high, and we suggest that such cases should be further investigated by abdominal ultrasound and isotope bone scan. While failure to respond to treatment with steroids should raise doubts about the diagnosis of PMR, a good response to steroids does not necessarily con®rm the diagnosis. In all three of the cases reported here there was a good initial response to steroids.
Patients Duodenal obstruction is present at diagnosis in about 5% of patients with adenocarcinoma of the head of the pancreas 1 . Surgical palliation was until recently the only means of improving their quality of life but duodenal stenting is now an option 2,3 .
CASE HISTORY
A man aged 55 with an irresectable adenocarcinoma of the pancreatic head had metallic Wallstents inserted in the bile duct and duodenum. Five months later he was admitted with acute right upper quadrant pain and right shoulder tip pain. He was apyrexial, anicteric and cardiovascularly stable. There was tenderness and guarding in the right upper quadrant but an erect chest X-ray showed no evidence of a pneumoperitoneum. Abdominal radiography revealed that the duodenal stent was now vertical (Figure 1) , having previously been C-shaped in the second part of the duodenum. Next day a computed tomographic scan of the abdomen revealed free peritoneal air and a small amount of free¯uid in the gallbladder fossa and around the duodenum. At laparotomy there was diffuse peritonitis together with a prepyloric perforation, approximately 3 mm in size, through which the edge of the stent could be felt. The perforation was closed with an omental patch. The patient died soon after the operation.
COMMENT
Metallic stents have an established place in the treatment of biliary and oesophageal obstruction but experience of their use in the duodenum is limited 1 . One reason is a perception that metallic stents placed in the bowel are prone to migration or liable to cause perforation 2 . Our suspicion that there might be a duodenal perforation in the present case 
